Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2 12/26/2023 INTERVENTIONAL unchanged 974.85 0 Tender Loving Care for Recurrent Pregnancy Loss 12/27/2023 INTERVENTIONAL unchanged 973.85 0 A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. 12/27/2023 INTERVENTIONAL unchanged 973.85 0 Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot 12/28/2023 OBSERVATIONAL unchanged 972.85 0 Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy 12/28/2023 INTERVENTIONAL unchanged 972.85 0 Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women 12/28/2023 INTERVENTIONAL unchanged 972.85 0 Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial 12/28/2023 INTERVENTIONAL unchanged 972.85 0 ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy 12/29/2023 INTERVENTIONAL unchanged 971.85 0 FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy 12/29/2023 OBSERVATIONAL unchanged 971.85 0 International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS) 12/29/2023 OBSERVATIONAL unchanged 971.85 0 Hypertension Explored in Long-term Postpartum Follow-up in Later Life 01/02/2024 OBSERVATIONAL unchanged 967.85 0 A Nutrition and Exercise Lifestyle Intervention Program Participant Choice Approach 01/02/2024 INTERVENTIONAL unchanged 967.85 0 Induction ATAD Catheter and Lower Segment Thickness 01/03/2024 INTERVENTIONAL unchanged 966.85 0 Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram 01/03/2024 OBSERVATIONAL unchanged 966.85 0 The Effects of Remimazolam on the Incidence of Severe Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients 01/03/2024 INTERVENTIONAL unchanged 966.85 0 An Informative Video Before Planned External Cephalic Version 01/03/2024 INTERVENTIONAL unchanged 966.85 0 Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS 01/03/2024 INTERVENTIONAL unchanged 966.85 0 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors 01/03/2024 INTERVENTIONAL unchanged 966.85 0 Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) 01/03/2024 INTERVENTIONAL unchanged 966.85 0 Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD) 01/05/2024 INTERVENTIONAL unchanged 964.85 0 Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study 01/05/2024 INTERVENTIONAL unchanged 964.85 0 Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy 01/05/2024 INTERVENTIONAL unchanged 964.85 0 Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma 01/05/2024 INTERVENTIONAL unchanged 964.85 0 Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) 01/05/2024 INTERVENTIONAL unchanged 964.85 0 Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS) 01/08/2024 OBSERVATIONAL unchanged 961.85 0 Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction 01/08/2024 INTERVENTIONAL unchanged 961.85 0 Autologous vs. Implant-based Breast Reconstruction 01/08/2024 INTERVENTIONAL unchanged 961.85 0 Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer 01/09/2024 OBSERVATIONAL unchanged 960.85 0 Breast Lesion in CT Chest 01/09/2024 OBSERVATIONAL unchanged 960.85 0 Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity 01/09/2024 INTERVENTIONAL unchanged 960.85 0 Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women 01/09/2024 INTERVENTIONAL unchanged 960.85 0 Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer 01/09/2024 INTERVENTIONAL unchanged 960.85 0 Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women 01/09/2024 OBSERVATIONAL unchanged 960.85 0 Induction of Labor in Morbidly Obese Patients 01/10/2024 INTERVENTIONAL unchanged 959.85 0 Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan 01/10/2024 INTERVENTIONAL unchanged 959.85 0 Identification of Y Chromosome From Free Circulating DNA in Patients With Turner Syndrome 01/12/2024 INTERVENTIONAL unchanged 957.85 0 Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model 01/12/2024 INTERVENTIONAL unchanged 957.85 0 Study of the Identification of Childbirth Trauma in the Birth Room by Midwives. 01/12/2024 OBSERVATIONAL unchanged 957.85 0 New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome 01/12/2024 INTERVENTIONAL unchanged 957.85 0 A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD 01/12/2024 INTERVENTIONAL unchanged 957.85 0 Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis 01/16/2024 OBSERVATIONAL unchanged 953.85 0 The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System 01/16/2024 INTERVENTIONAL unchanged 953.85 0 Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer 01/17/2024 INTERVENTIONAL unchanged 952.85 0 Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery 01/17/2024 INTERVENTIONAL unchanged 952.85 0 Multimodal Physiotherapy Based on Tele-rehabilitation in Chronic Pelvic Pain Associated With Endometriosis 01/17/2024 INTERVENTIONAL unchanged 952.85 0 Community Health Worker-Led Postpartum Diabetes Screening 01/17/2024 INTERVENTIONAL unchanged 952.85 0 Speculum Insertion During Embryo Transfer 01/18/2024 INTERVENTIONAL unchanged 951.85 0 Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ 01/18/2024 INTERVENTIONAL unchanged 951.85 0 MY-ENDO -- Mind Your ENDOmetriosis: a Digital Mindfulness- and Acceptance-based Endometriosis Self-management Program 01/18/2024 INTERVENTIONAL unchanged 951.85 0 Study of the Prevalence of Endometriosis and Adenomyosis 01/18/2024 OBSERVATIONAL unchanged 951.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology